Bavarian Nordic is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases.
Our pipeline comprises multiple product candidates for infectious diseases and cancer. Many of our programs are supported by external funding through either private or governmental partnerships.
Bavarian Nordic is committed to providing our shareholders and the media with reliable and transparent information about our business, development programs and results in an open and timely manner
Bavarian Nordic offers a challenging international working environment in which job satisfaction and personal growth have a high priority.